4Zhang ZX, Roman GC, Hong Z, ed al. Parkinson's disease in China; prevalence in Beijing, xian, and Shanghai [J]. Lancet, 2005, 365 (9459) : 595 -597.
5Parkison Study Group. Effects of tecophrol and tecopherol and deprenyl on the Progression of disability in early Parkinson's diease[J]. N Engl J Med, I993, 328: 176-183.
6shults CW, Oakes D, kieburtz K, et al. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the fanctiondl decline [J]. Arch Neural, 2002, 59:1541-1550.
7Albin RL, Frey KA. Initial agonist treatment of Parkinson disease [J]. Neurelogy, 2003, 60: 390-394.
8Olanow W, Schapira AH, Rascol O. Continuous dopamine - receptor stimulation in early Parkinson's disease [ J ]. Trends Neurosci, 2000, 23 (10suppl): s117-s126.
9The Swedish Parkinson Study Group. selegiline slows the rorgression of the symptoms of Parkinson disease [ J ]. Neurolgy, 2006, 66 ( 8 ) : 1200 - 1206.
10Keating GM, Perry CM. Spotlight on rasagiline in Parkison's disease [J]. CNSDmgs, 2008, 22 (1): 83-86.
